Rubidium Chloride Rb 82

CHEMBL1200727 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
117.4 g/mol
LogP
Phase
4

Rubidium chloride Rb-82 is a radiopharmaceutical used as a myocardial perfusion agent in positron emission tomography (PET) imaging to evaluate coronary artery disease and cardiac perfusion defects. Rubidium-82 is a potassium analog actively transported into viable myocardial cells via the Na/K-ATPase pump, with areas of reduced uptake indicating ischemia or infarction. Its very short half-life of 75 seconds requires on-site generation from a strontium-82/rubidium-82 generator.

Masse moléculaire

117,3700 g/mol

TPSA

0,00 Ų

Mécanisme d'action

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[82Rb+].[Cl-]

InChI

InChI=1S/ClH.Rb/h1H;/q;+1/p-1/i;1-3

Molecular Formula

ClRb

HBD / HBA

- / 1

Liaisons Rotatives

0

Atomes Lourds

2

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Rubidium chloride Rb-82 is a radiopharmaceutical used as a myocardial perfusion agent in positron emission tomography (PET) imaging to evaluate coronary artery disease and cardiac perfusion defects. Rubidium-82 is a potassium analog actively transported into viable myocardial cells via the Na/K-ATPase pump, with areas of reduced uptake indicating ischemia or infarction. Its very short half-life of 75 seconds requires on-site generation from a strontium-82/rubidium-82 generator.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Rubidium Chloride Rb 82 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200727. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71357. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.